Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew H. Payne is active.

Publication


Featured researches published by Andrew H. Payne.


Bioorganic & Medicinal Chemistry Letters | 2009

Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors.

John B. Porter; Andrew H. Payne; Ben de Candole; Daniel Ford; Brian Hutchinson; Graham Trevitt; James M. A. Turner; Chloe Edwards; Clare Watkins; Ian Whitcombe; Jeremy Martin Davis; Colin Stubberfield

Anti-apoptotic Bcl-2 protects cells from apoptosis by binding to pro-apoptotic members of the Bcl-2 family thereby playing a role in tumour survival in response to chemo- or radiation therapy. We describe a series of phenyl pyrazoles that have high affinity for Bcl-2 and rationalise the observed SAR by means of an X-ray crystal structure.


Bioorganic & Medicinal Chemistry Letters | 2009

Atropisomeric small molecule Bcl-2 ligands : Determination of bioactive conformation

John B. Porter; Andrew H. Payne; Ian Whitcombe; Ben de Candole; Daniel Ford; Rachel A. Garlish; Adam Hold; Brian Hutchinson; Graham Trevitt; James M. A. Turner; Chloe Edwards; Clare Watkins; Jeremy Martin Davis; Colin Stubberfield

The separation of atropisomeric conformers of 1,2,3,4-tetrahydroisoquinoline amide Bcl-2 ligands allowed the identification of the bioactive conformer which was subsequently confirmed by X-ray crystallography.


Bioorganic & Medicinal Chemistry Letters | 2010

The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.

Ian P. Holmes; Richard Blunt; Olivier Lorthioir; Stephen M. Blowers; Andy Gribble; Andrew H. Payne; Ian G. Stansfield; Martyn D. Wood; Patrick M. Woollard; Charlie Reavill; Claire M. Howes; Fabrizio Micheli; Romano Di Fabio; Daniele Donati; Silvia Terreni; Dieter Hamprecht; Luca Arista; Angela Worby; Steve P. Watson

The identification of a highly selective D(2) partial agonist, D(3) antagonist tool molecule which demonstrates high levels of brain exposure and selectivity against an extensive range of dopamine, serotonin, adrenergic, histamine, and muscarinic receptors is described.


Bioorganic & Medicinal Chemistry Letters | 2007

Studies towards the identification of a new generation of atypical antipsychotic agents

Vincenzo Garzya; Ian Thomson Forbes; Andrew Derrick Gribble; Mike S. Hadley; Andrew P. Lightfoot; Andrew H. Payne; Alexander Baxter Smith; Sara E. Douglas; David Gwyn Cooper; Ian Stansfield; Malcom Meeson; Emma E. Dodds; Declan N.C. Jones; Martyn D. Wood; Charlie Reavill; Carol A. Scorer; Angela Worby; Graham J. Riley; Peter Eddershaw; Chris Ioannou; Daniele Donati; Jim J. Hagan; Emiliangelo Ratti


Tetrahedron Letters | 2005

First organophosphorus radical-mediated cyclisations to afford medium-sized rings : eight-membered lactones and seven- and eight-membered lactams

Stuart Lang; Michael J. Corr; Neil Muir; Tanweer A. Khan; Franziska Schönebeck; John A. Murphy; Andrew H. Payne; Andrew Caerwyn Williams


Angewandte Chemie | 2008

Stereoselective Dearomatizing Addition of Nucleophiles to Uncomplexed Benzene Rings: A Route to Carbocyclic Sugar Analogues

Jonathan Clayden; Sean Parris; Nuria Cabedo; Andrew H. Payne


Organic Letters | 2003

Amination of arenes through electron-deficient reaction cascades of aryl epoxyazides

Stuart Lang; Alan R. Kennedy; John A. Murphy; Andrew H. Payne


Archive | 2003

Benzenesulfonamide derivatives as antipsychotic agents

Steven Mark Bromidge; David Gwyn Cooper; Ian Thomson GlaxoSmithKline Forbes; Andrew Derrick GlaxoSmithKline Gribble; Christopher Norbert GlaxoSmithKline Johnson; Andrew P. Lightfoot; Stephen Frederick Moss; Andrew H. Payne; Shahzad Sharooq GlaxoSmithKline Rahman; David R. Witty


Archive | 2003

Dopamine receptor modulators as antipsychotic agents

David Gwyn Cooper; Ian Thomson GlaxoSmithKline Forbes; Andrew Derrick GlaxoSmithKline Gribble; Andrew Glaxosmithkline Lightfoot; Andrew H. Payne


Archive | 2003

Sulfonamide derivatives as antipsychotic agents

Ian Thomson Forbes; Andrew Derrick Gribble; Andrew P. Lightfoot; Andrew H. Payne

Collaboration


Dive into the Andrew H. Payne's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge